FDA: AWARDED NATIONAL PRIORITY VOUCHER TO TECLISTAMAB IN COMBINATION WITH DARATUMUMAB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

Reuters · 2d ago

Please log in to view news